Gossamar Bio- $330,000,000.Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Rakuten Aspyrian-$150,000,000. Rakuten Aspyrianis a privately funded clinical stage biotechnology company developing tumor-targeted precision therapies based on the new platform Photoimmunotherapy (PIT).
Mirium Pharmaceuticals - $120,000,000. Mirum Pharmaceuticals Inc. is a clinical-stage therapeutics company developing a novel approach for treating cholestatic liver diseases, with an immediate focus on rare pediatric conditions.
TP Therapeutics - $80,000,000. TP Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care.
Crinetics Pharmaceuticals - $66,700,000. Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers.
Neurana Pharmaceuticals - $60,000,000.Neurana Pharmaceuticals is a specialty pharmaceutical company focused on the treatment of neuromuscular conditions
Neurelis - $40,500,000. Neurelis is a specialty pharmaceutical firm that licenses, develops, and commercializes product candidates for epilepsy and the CNS market.
QPex Biopharma - $33,000,000. Qpex Biopharma is developing a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings.
Mistral Therapeutics - $25,900,000. Mistral Therapeutics operates as a biotechnology company developing medicines to treat fibrosis.
NetraDyne - $21,000,000. NetraDyne is a software company that creates solutions to real world problems using computer vision and deep learning technologies.